Abstract:Kyung-Ok-Ko (KOK), a traditional herbal prescription composed of Rehmannia glutinosa Liboschitz var. purpurae, Lycium chinense, Aquillaria agallocha, Poria cocos, Panax ginseng, and honey, has been widely used in traditional Oriental medicine as a vitalizing medicine or as the prescription for patients with age-associated disorders such as amnesia and stroke. However, the potential protective value of KOK for the treatment of polycystic ovarian syndrome (PCOS) is largely unknown. We investigated whether pre-ad… Show more
“…In this study, we investigated IR in PCOS model rats by measuring fasting blood insulin and glucose and calculating the HOMA-IR index. In line with previous reports [16], our data demonstrated stimulated IR in DHEA-treated ovaries which was then readily alleviated by oral administration of HLF.…”
Section: Discussionsupporting
confidence: 93%
“…The method for establishment of PCOS rat model referred to the protocol described by Jang et al [16]. The experimental schema is illustrated in Figure 1.…”
Section: Resultsmentioning
confidence: 99%
“…Sander et al [19] demonstrated that metformin restored ovulation in PCOS and improved ovarian-related parameters in DHEA androgenized mice. Jang et al [16] reported that the oriental medicine, Kyung-ok-ko, decreased the size and number of follicular cysts, restored estrous cycle arrest, and decreased elevated serum estradiol in PCOS rats. We assessed the effect of HLF against PCOS in the DHEA-induced disease model.…”
Objective: To evaluate the potential beneficial effects of hawthorn leaf flavonoids (HLF) against polycystic ovary syndrome (PCOS) in a rat model of disease and elucidate the underlying molecular mechanism. Methods: The PCOS model was established by subcutaneous injection of dehydroepiandrosterone (DHEA, 60 mg/kg/day) for 21 consecutive days. HLF (200 mg/kg/day) were orally administered simultaneously or after the injection. The body weight was regularly monitored and recorded. The ovaries were weighed and histologically examined via hematoxylin and eosin staining. The number of follicular cysts was counted under a light microscope. The serous hormones were measured using enzyme-linked immunosorbent assay kits. Insulin resistance (IR) was calculated as HOMA-IR = fasting insulin (µU/L) × fasting glucose (mM)/22.5. The estrous cycle was determined by vaginal smear. The relative expression of tumor necrosis factor-α and interleukin-6 was measured by real-time polymerase chain reaction. The superoxide dismutase activity and malondialdehyde content was determined using commercially available kits. Results: DHEA induced a significant increase of body weight, ovary weight, number of follicular cysts, serous hormones, IR, inflammatory cytokines, and oxidative stress, and it also impaired the estrous cycle. Oral administration of HLF greatly alleviated these complications. Little toxicity of HLF was observed in our rat model. Conclusion: HLF manifest protective effects against PCOS progression in the animal model, which may hold great promise for future clinical applications.
“…In this study, we investigated IR in PCOS model rats by measuring fasting blood insulin and glucose and calculating the HOMA-IR index. In line with previous reports [16], our data demonstrated stimulated IR in DHEA-treated ovaries which was then readily alleviated by oral administration of HLF.…”
Section: Discussionsupporting
confidence: 93%
“…The method for establishment of PCOS rat model referred to the protocol described by Jang et al [16]. The experimental schema is illustrated in Figure 1.…”
Section: Resultsmentioning
confidence: 99%
“…Sander et al [19] demonstrated that metformin restored ovulation in PCOS and improved ovarian-related parameters in DHEA androgenized mice. Jang et al [16] reported that the oriental medicine, Kyung-ok-ko, decreased the size and number of follicular cysts, restored estrous cycle arrest, and decreased elevated serum estradiol in PCOS rats. We assessed the effect of HLF against PCOS in the DHEA-induced disease model.…”
Objective: To evaluate the potential beneficial effects of hawthorn leaf flavonoids (HLF) against polycystic ovary syndrome (PCOS) in a rat model of disease and elucidate the underlying molecular mechanism. Methods: The PCOS model was established by subcutaneous injection of dehydroepiandrosterone (DHEA, 60 mg/kg/day) for 21 consecutive days. HLF (200 mg/kg/day) were orally administered simultaneously or after the injection. The body weight was regularly monitored and recorded. The ovaries were weighed and histologically examined via hematoxylin and eosin staining. The number of follicular cysts was counted under a light microscope. The serous hormones were measured using enzyme-linked immunosorbent assay kits. Insulin resistance (IR) was calculated as HOMA-IR = fasting insulin (µU/L) × fasting glucose (mM)/22.5. The estrous cycle was determined by vaginal smear. The relative expression of tumor necrosis factor-α and interleukin-6 was measured by real-time polymerase chain reaction. The superoxide dismutase activity and malondialdehyde content was determined using commercially available kits. Results: DHEA induced a significant increase of body weight, ovary weight, number of follicular cysts, serous hormones, IR, inflammatory cytokines, and oxidative stress, and it also impaired the estrous cycle. Oral administration of HLF greatly alleviated these complications. Little toxicity of HLF was observed in our rat model. Conclusion: HLF manifest protective effects against PCOS progression in the animal model, which may hold great promise for future clinical applications.
“…Ovary weight in postnatal DHEA‐treated rats was increased relative to that in controls; this was accompanied by ovarian cyst expansion, an increased number of cystic follicles, granular cell layer thinning, and thickening of the theca cell layer . DHEA‐treated mice showed normal ovary weight and growing follicle and CL populations …”
Background
Polycystic ovary syndrome (PCOS) is a common endocrine disorder among women of reproductive age and a major cause of infertility; however, the pathophysiology of this syndrome is not fully understood. This can be addressed using appropriate animal models of PCOS. In this review, we describe rodent models of hormone‐induced PCOS that focus on the perturbation of the hypothalamic‐pituitary‐ovary (HPO) axis and abnormalities in neuropeptide levels.
Methods
Comparison of rodent models of hormone‐induced PCOS.
Main findings
The main method used to generate rodent models of PCOS was subcutaneous injection or implantation of androgens, estrogens, antiprogestin, or aromatase inhibitor. Androgens were administered to animals pre‐ or postnatally. Alterations in the levels of kisspeptin and related molecules have been reported in these models.
Conclusion
The most appropriate model for the research objective and hypothesis should be established. Dysregulation of the HPO axis followed by elevated serum luteinizing hormone levels, hyperandrogenism, and metabolic disturbance contribute to the complex etiology of PCOS. These phenotypes of the human disease are recapitulated in hormone‐induced PCOS models. Thus, evidence from animal models can help to clarify the pathophysiology of PCOS.
“…These results indicated that adlay extracts also contain components that could inhibit signal transduction pathways of the androgen receptor. Jang et al (2014) demonstrated that the traditional Chinese herb Kyung-Ok-Ko (KOK; qiong-yu-gao in Chinese; kei-gyokukou in Japanese) is a traditional Oriental medicine that can improve DHEA-induced PCOS in animal models. This study also used an animal model of DHEA-induced PCOS to demonstrate that the AHE-EA possessed significant inhibitory effects on hyperandrogenemia in PCOS rats; the AHE-EA improved IR, oxidative stress, liver function, and inflammatory responses in PCOS rats.…”
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.